Intra-Arterial Administration of Stem Cells and Exosomes for Central Nervous System Disease
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26157405 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Taishi Honda und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Hokkaido University Graduate School of Medicine, Kita 15, Nishi 7, Kita-ku, Sapporo 060-8638, Hokkaido, Japan. Hauptthemen laut MEDLINE: Exosomes, Central Nervous System Diseases, Stem Cell Transplantation, Stem Cells. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 120 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: KAKENHI.
Abstract (Originalsprache)
Central nervous system (CNS) disorders present significant therapeutic challenges due to the limited regenerative capacity of neural tissues, resulting in long-term disability for many patients. Consequently, the development of novel therapeutic strategies is urgently warranted. Stem cell therapies show considerable potential for mitigating brain damage and restoring neural connectivity, owing to their multifaceted properties, including anti-apoptotic, anti-inflammatory, neurogenic, and vasculogenic effects. Recent research has also identified exosomes—small vesicles enclosed by a lipid bilayer, secreted by stem cells—as a key mechanism underlying the therapeutic effects of stem cell therapies, and given their enhanced stability and superior blood–brain barrier permeability compared to the stem cells themselves, exosomes have emerged as a promising alternative treatment for CNS disorders. A key challenge in the application of both stem cell and exosome-based therapies for CNS diseases is the method of delivery. Currently, several routes are being investigated, including intracerebral, intrathecal, intravenous, intranasal, and intra-arterial administration. Intracerebral injection can deliver a substantial quantity of stem cells directly to the brain, but it carries the potential risk of inducing additional brain injury. Conversely, intravenous transplantation is minimally invasive but results in limited delivery of cells and exosomes to the brain, which may compromise the therapeutic efficacy. With advancements in catheter technology, intra-arterial administration of stem cells and exosomes has garnered increasing attention as a promising delivery strategy. This approach offers the advantage of delivering a significant number of stem cells and exosomes to the brain while minimizing the risk of additional brain damage. However, the investigation into the therapeutic potential of intra-arterial transplantation for CNS injury is still in its early stages. In this comprehensive review, we aim to summarize both basic and clinical research exploring the intra-arterial administration of stem cells and exosomes for the treatment of CNS diseases. Additionally, we will elucidate the underlying therapeutic mechanisms and provide insights into the future potential of this approach.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, Hokkaido University Graduate School of Medicine, Kita 15, Nishi 7, Kita-ku, Sapporo 060-8638, Hokkaido, Japan.
ORCID-Profile: Masahito Kawabori
Förderung
- KAKENHI
Zitieren
APA
Honda, T., Kawabori, M., & Fujimura, M. (2025). Intra-Arterial Administration of Stem Cells and Exosomes for Central Nervous System Disease. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26157405
Vancouver
Honda T, Kawabori M, Fujimura M. Intra-Arterial Administration of Stem Cells and Exosomes for Central Nervous System Disease. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26157405
BibTeX
@article{Honda2025,
author = {Honda, Taishi and Kawabori, Masahito and Fujimura, Miki},
title = {Intra-Arterial Administration of Stem Cells and Exosomes for Central Nervous System Disease},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26157405}
}
EUVIMED